Park Circle Company’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Park Circle Company's BMY Position: Q1 2026 in Review
Park Circle Company held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 11,700 shares worth $710K. The position accounts for 0.66% of the portfolio, ranked #33.
Park Circle Company first reported a position in BMY in Q3 2016 and has held it in 22 quarters since. The position peaked at $714K in Q1 2025. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Park Circle Company held 11,700 shares of Bristol-Myers Squibb worth $710K as of Q1 2026.
- Park Circle Company left its Bristol-Myers Squibb share count unchanged in Q1 2026.
- Bristol-Myers Squibb made up 0.66% of Park Circle Company's portfolio in Q1 2026, its #33 holding.
- Park Circle Company first reported a position in Bristol-Myers Squibb in Q3 2016 and has held it in 22 quarters since.
- Park Circle Company's Bristol-Myers Squibb position peaked at $714K in Q1 2025.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Park Circle Company's 13F filing for Q1 2026, filed 14 May 2026.